Production (Stage)
Galectin Therapeutics Inc.
GALT
$1.37
$0.032.24%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -68.45% | -41.08% | 32.89% | 42.48% | 32.34% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -2.68% | -49.80% | 28.58% | 12.45% | 8.67% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 18,333.33% | -- | -- | -- |
| Total Current Assets | -63.53% | -37.74% | 32.65% | 40.16% | 30.22% |
|
|
|||||
| Total Current Assets | -63.53% | -37.74% | 32.65% | 40.16% | 30.22% |
| Net Property, Plant & Equipment | 46.67% | -65.22% | -58.06% | -50.00% | -42.31% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -54.03% | -48.87% | -42.86% | -38.67% | -35.29% |
| Total Assets | -63.20% | -37.96% | 30.72% | 37.72% | 28.01% |
|
|
|||||
| Total Accounts Payable | 72.08% | -12.05% | 4.25% | 87.15% | 48.73% |
| Total Accrued Expenses | -22.31% | -10.41% | 48.20% | 37.38% | -1.68% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 202,981.25% | 45,847.83% | 23,344.44% | 2.33% | 14.29% |
| Total Finance Division Other Current Liabilities | -- | 585.71% | -- | -1.56% | -- |
| Total Other Current Liabilities | -- | 585.71% | -- | -1.56% | -- |
| Total Current Liabilities | 777.38% | 125.88% | 140.05% | 46.86% | 9.54% |
|
|
|||||
| Total Current Liabilities | 777.38% | 125.88% | 140.05% | 46.86% | 9.54% |
| Long-Term Debt | -87.02% | 18.63% | 50.50% | 52.62% | 64.45% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -87.27% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -95.32% | -- | 176,300.00% | -- |
| Total Liabilities | 25.59% | 36.32% | 66.29% | 54.20% | 54.25% |
|
|
|||||
| Common Stock & APIC | 1.41% | 1.50% | 1.25% | 6.15% | 5.92% |
| Retained Earnings | -12.38% | -13.32% | -13.14% | -14.54% | -13.94% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -56.17% | -68.57% | -78.33% | -58.11% | -63.35% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | 0.00% | -0.45% | -0.45% | -0.45% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | -0.45% | -0.45% | -0.45% |
|
|
|||||
| Total Common Equity | -56.17% | -68.57% | -78.33% | -58.11% | -63.35% |
| Total Preferred Equity | 0.00% | 0.00% | -0.45% | -0.45% | -0.45% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -57.92% | -71.10% | -81.79% | -60.67% | -66.69% |
|
|
|||||